GLP-1 medications will likely expand beyond their current uses for diabetes or weight loss, according to money managers at Tema
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
Read Next
- Senate review of Supreme Court ethics urges enforceable conduct code
- 9 signs someone isn’t actually nice, they’re a just a people-pleaser
- 6 types of family members who can be very difficult to live with, according to psychology
- If you really want to overcome your difficult childhood, say goodbye to these 7 habits
- HDFC Securities expects India GDP to moderate to 6.4% in 2024-25, ET BFSI
- House Democrats say GOP caved to Elon Musk, protecting China interests
- Trump taps ‘Apprentice’ producer, Mark Burnett, as special envoy to the United Kingdom
